Proteinase-activated receptor-2 blockade inhibits changes seen in a chronic murine asthma model.
M AsaduzzamanC DavidsonD NahirneyY FiteihL PuttaguntaHarissios VliagoftisPublished in: Allergy (2017)
Our data demonstrate that PAR2 signaling plays a key role in CE-induced AHR and airway inflammation/remodeling in long term models of allergic airway inflammation. Targeting PAR2 activation may be a successful therapeutic strategy for allergic asthma.